Donepezil/memantine - Merz Pharmaceuticals GmbH
Alternative Names: Balaxur; Memantine/donepezil - Merz Pharmaceuticals GmbHLatest Information Update: 30 Oct 2021
At a glance
- Originator Merz Pharmaceuticals GmbH
- Class Analgesics; Antidementias; Antiparkinsonians; Antispastics; Indans; Nootropics; Organic bridged compounds; Piperidines; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 20 Nov 2018 No recent reports of development identified after preregistration for Alzheimer's disease (Combination therapy, Treatment-experienced) in European Union (PO)